News & Perspective

Nov 06, 2017

Nov 06, 2017

News Scan for Nov 06, 2017

Strep burden, resistance threat
Salmonella probe ends
Ebola susceptibility
MDR-TB in Minnesota

Oct 11, 2017

Oct 11, 2017
Ebola vaccine study

Liberia trial finds Ebola vaccines yield year-long immune response

A trial at the end of Liberia's Ebola outbreak shows 2 candidate vaccines posed no major safety concerns and triggered immune responses that lasted at least a year.

Oct 12, 2016

Oct 12, 2016
ZMapp Ebola drug research

Trial offers mixed view of Ebola drug ZMapp

"I would view the results . . . in an optimistic light," said lead author Richard Davey after the drug showed more than 90% efficacy.

Aug 16, 2016

Aug 16, 2016

News Scan for Aug 16, 2016

Malaria may boost Ebola survival
Scallop hepatitis A source
Inhaled vs injectable flu vaccine
Camels and human cold virus
Venezuela malaria spike

Feb 25, 2016

Feb 25, 2016
Ebola survivor in Liberia

Studies on Ebola survivors show range of complications

Findings include neurologic problems and a potential for virus survival in semen for 18 months.

Jul 15, 2015

Jul 15, 2015
Freetown street scene

Ebola activity steady, back in Guinea and Sierra Leone capitals

Also, phase 2 trials just launched for two prime-boost Ebola vaccine regimens.

Mar 27, 2015

Mar 27, 2015
Syringe on vials

Two Ebola vaccines shown safe as next step pondered

The findings clear the way for the next step, which may require a change in venue.

Mar 26, 2015

Mar 26, 2015
Ebola virus

Gene study finds no worrisome changes in Ebola virus

The virus may be more stable than a study in August found.

Mar 17, 2015

Mar 17, 2015
Vials and syringe

Emergent announces human trial for boosted Ebola vaccine

Other Ebola developments include the departure of Cuba's team from Liberia, new information on evacuee contact monitoring, and outbreak case totals.

Feb 27, 2015

Feb 27, 2015
Ebola treatment in Guinea

Trial of Ebola drug ZMapp launches in Liberia, US

Steeply dropping cases, though, may cause the NIAID to vary from the original trial design.

Pages

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»